
GTC highlights Liquid Trace® CSF testing as NCCN updates support CSF-based molecular profiling for inoperable gliomas and glioblastomas.

A pilot feasibility study published in Blood Neoplasia demonstrates the potential of comprehensive cfDNA + cfRNA liquid biopsy for molecular profiling in cutaneous T-cell lymphoma (CTCL). Using GTC’s high-depth NGS platform,